Pediatric teledermatology: A retrospective review of 1199 encounters during the COVID-19 pandemic

Abstract

To the Editor: The incorporation of telemedicine into routine dermatologic care during COVID-19 has created new opportunities to evaluate and optimize our existing teledermatology platforms. Previous pediatric studies have shown that teledermatology improves access to care1,2 while offering opportunities to improve show rates and reduce wait times.3 We performed a retrospective review of 1110 video visits (live, interactive, patient-to-provider) and 89 e-consults (store-and-forward, provider-to-provider) during the early COVID-19 pandemic (March 18 to May 1, 2020) to acquire key information on continued applications of teledermatology.